Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 890

1.

The difficulty of diagnosing NCSE in clinical practice; external validation of the Salzburg criteria.

Goselink RJM, van Dillen JJ, Aerts M, Arends J, van Asch C, van der Linden I, Pasman J, Saris CGJ, Zwarts M, van Alfen N.

Epilepsia. 2019 Jul 18. doi: 10.1111/epi.16289. [Epub ahead of print]

PMID:
31318040
2.

Introducing hepatitis C virus healthcare pathways in addiction care in the Netherlands with a Breakthrough project: a mixed method study.

Kracht PAM, de Gee EA, van der Poel A, Verhagen MAMT, Hoepelman AIM, Croes EA, Arends JE.

Harm Reduct J. 2019 Jul 15;16(1):45. doi: 10.1186/s12954-019-0316-4.

3.

The use of corticosteroids does not influence CD4+ lymphocyte recovery in HIV-infected patients with advanced immunodeficiency.

van Welzen BJ, de Vries TI, Arends JE, Mudrikova T, Hoepelman AIM.

AIDS Care. 2019 May 27:1-4. doi: 10.1080/09540121.2019.1623376. [Epub ahead of print]

PMID:
31132873
4.

Predictive Performance of Cardiovascular Disease Risk Prediction Algorithms in People Living With HIV.

van Zoest RA, Law M, Sabin CA, Vaartjes I, van der Valk M, Arends JE, Reiss P, Wit FW.

J Acquir Immune Defic Syndr. 2019 Aug 15;81(5):562-571. doi: 10.1097/QAI.0000000000002069.

PMID:
31045648
5.

Switching tenofovir disoproxil fumarate to tenofovir alafenamide results in a significant decline in parathyroid hormone levels: uncovering the mechanism of tenofovir disoproxil fumarate-related bone loss?

Van Welzen BJ, Thielen MAJ, Mudrikova T, Arends JE, Hoepelman AIM.

AIDS. 2019 Jul 15;33(9):1531-1534. doi: 10.1097/QAD.0000000000002238.

PMID:
31021851
6.

Home parenteral nutrition provision modalities for chronic intestinal failure in adult patients: An international survey.

Pironi L, Steiger E, Brandt C, Joly F, Wanten G, Chambrier C, Aimasso U, Sasdelli AS, Zeraschi S, Kelly D, Szczepanek K, Jukes A, Di Caro S, Theilla M, Kunecki M, Daniels J, Serlie M, Poullenot F, Wu J, Cooper SC, Rasmussen HH, Compher C, Seguy D, Crivelli A, Pagano MC, Hughes SJ, Guglielmi FW, Kozjek NR, Schneider SM, Gillanders L, Ellegard L, Thibault R, Matras P, Zmarzly A, Matysiak K, Van Gossum A, Forbes A, Wyer N, Taus M, Virgili NM, O'Callaghan M, Chapman B, Osland E, Cuerda C, Sahin P, Jones L, Won Lee AD, Masconale L, Orlandoni P, Izbéki F, Spaggiari C, Bueno M, Doitchinova-Simeonova M, Garde C, Serralde-Zúñiga AE, Olveira G, Krznaric Z, Czako L, Kekstas G, Sanz-Paris A, Jáuregui EP, Murillo AZ, Schafer E, Arends J, Suárez-Llanos JP, Lal S; Home Artificial Nutrition and Chronic Intestinal Failure Special Interest Group of ESPEN; European Society for Clinical Nutrition and Metabolism.

Clin Nutr. 2019 Mar 25. pii: S0261-5614(19)30123-2. doi: 10.1016/j.clnu.2019.03.010. [Epub ahead of print]

PMID:
30992207
7.

Assessing Evidence and the Need for High-Quality Research in Clinical Nutrition.

Arends J.

Nutr Clin Pract. 2019 Jun;34(3):477. doi: 10.1002/ncp.10305. Epub 2019 Apr 9. No abstract available.

PMID:
30968448
8.

Design and methods of the 'monitoring outcomes of psychiatric pharmacotherapy' (MOPHAR) monitoring program - a study protocol.

Simoons M, Ruhé HG, van Roon EN, Schoevers RA, Bruggeman R, Cath DC, Muis D, Arends J, Doornbos B, Mulder H.

BMC Health Serv Res. 2019 Feb 14;19(1):125. doi: 10.1186/s12913-019-3951-2.

9.

Intricate Crosstalk Between Lipopolysaccharide, Phospholipid and Fatty Acid Metabolism in Escherichia coli Modulates Proteolysis of LpxC.

Thomanek N, Arends J, Lindemann C, Barkovits K, Meyer HE, Marcus K, Narberhaus F.

Front Microbiol. 2019 Jan 14;9:3285. doi: 10.3389/fmicb.2018.03285. eCollection 2018.

10.

Treatment of acute hepatitis C genotypes 1 and 4 with 8 weeks of grazoprevir plus elbasvir (DAHHS2): an open-label, multicentre, single-arm, phase 3b trial.

Boerekamps A, De Weggheleire A, van den Berk GE, Lauw FN, Claassen MAA, Posthouwer D, Bierman WF, Hullegie SJ, Popping S, van de Vijver DACM, Dofferhoff ASM, Kootstra GJ, Leyten EM, den Hollander J, van Kasteren ME, Soetekouw R, Ammerlaan HSM, Schinkel J, Florence E, Arends JE, Rijnders BJA.

Lancet Gastroenterol Hepatol. 2019 Apr;4(4):269-277. doi: 10.1016/S2468-1253(18)30414-X. Epub 2019 Jan 17.

PMID:
30660617
11.

A Review of Non-Alcoholic Fatty Liver Disease in HIV-Infected Patients: The Next Big Thing?

van Welzen BJ, Mudrikova T, El Idrissi A, Hoepelman AIM, Arends JE.

Infect Dis Ther. 2019 Mar;8(1):33-50. doi: 10.1007/s40121-018-0229-7. Epub 2019 Jan 3. Review.

12.

Epileptic seizures associated with syncope: Ictal bradycardia and ictal asystole.

Monté CP, Monté CJ, Boon P, Arends J.

Epilepsy Behav. 2019 Jan;90:168-171. doi: 10.1016/j.yebeh.2018.10.027. Epub 2018 Dec 19. Review.

PMID:
30576964
13.

Overcoming Obstacles in Lipid-lowering Therapy in Patients with HIV - A Systematic Review of Current Evidence.

Dekkers CC, Westerink J, Hoepelman AIM, Arends JE.

AIDS Rev. 2018;20(4):205-219. doi: 10.24875/AIDSRev.18000016.

PMID:
30548018
14.

BEATVIC, a body-oriented resilience therapy using kickboxing exercises for people with a psychotic disorder: a feasibility study.

de Vries B, van der Stouwe ECD, Waarheid CO, Poel SHJ, van der Helm EM, Aleman A, Arends J, Pijnenborg GHM, van Busschbach JT.

BMC Psychiatry. 2018 Dec 11;18(1):384. doi: 10.1186/s12888-018-1958-6.

15.

Membrane stripping enables effective electrochemical ammonia recovery from urine while retaining microorganisms and micropollutants.

Christiaens MER, Udert KM, Arends JBA, Huysman S, Vanhaecke L, McAdam E, Rabaey K.

Water Res. 2019 Mar 1;150:349-357. doi: 10.1016/j.watres.2018.11.072. Epub 2018 Nov 30.

PMID:
30530129
16.

8 weeks of sofosbuvir/ledipasvir is effective in DAA-naive non-cirrhotic HCV genotype 4 infected patients (HEPNED-001 study).

Boerekamps A, Vanwolleghem T, van der Valk M, van den Berk GE, van Kasteren M, Posthouwer D, Dofferhoff ASM, van Hoek B, Ramsoekh D, Koopsen J, Schinkel J, Florence E, Arends JE, Rijnders BJ.

J Hepatol. 2019 Mar;70(3):554-557. doi: 10.1016/j.jhep.2018.10.032. Epub 2018 Dec 5. No abstract available.

PMID:
30527953
17.

An Acetobacterium strain isolated with metallic iron as electron donor enhances iron corrosion by a similar mechanism as Sporomusa sphaeroides.

Philips J, Monballyu E, Georg S, De Paepe K, Prévoteau A, Rabaey K, Arends JBA.

FEMS Microbiol Ecol. 2019 Feb 1;95(2). doi: 10.1093/femsec/fiy222.

PMID:
30445447
18.

Social cognitive group treatment for impaired insight in psychosis: A multicenter randomized controlled trial.

Pijnenborg GHM, de Vos AE, Timmerman ME, Van der Gaag M, Sportel BE, Arends J, Koopmans EM, Van der Meer L, Aleman A.

Schizophr Res. 2019 Apr;206:362-369. doi: 10.1016/j.schres.2018.10.018. Epub 2018 Nov 12.

PMID:
30429078
19.

Liver decompensation in HIV/Hepatitis B coinfection in the combination antiretroviral therapy era does not seem increased compared to hepatitis B mono-infection.

Lieveld FI, Smit C, Richter C, van Erpecum KJ, Spanier BWM, Gisolf EH, Vrolijk JM, Siersema PD, Hoepelman AIM, Reiss P, Arends JE.

Liver Int. 2019 Mar;39(3):470-483. doi: 10.1111/liv.14000. Epub 2018 Dec 2.

PMID:
30411848
20.

Multimodal nocturnal seizure detection in a residential care setting: A long-term prospective trial.

Arends J, Thijs RD, Gutter T, Ungureanu C, Cluitmans P, Van Dijk J, van Andel J, Tan F, de Weerd A, Vledder B, Hofstra W, Lazeron R, van Thiel G, Roes KCB, Leijten F; and the Dutch Tele-Epilepsy Consortium.

Neurology. 2018 Nov 20;91(21):e2010-e2019. doi: 10.1212/WNL.0000000000006545. Epub 2018 Oct 24.

21.

Strategies for achieving viral hepatitis C micro-elimination in the Netherlands.

Kracht PAM, Arends JE, van Erpecum KJ, Urbanus A, Willemse JA, Hoepelman AIM, Croes EA.

Hepatol Med Policy. 2018 Sep 29;3:12. doi: 10.1186/s41124-018-0040-9. eCollection 2018. Review.

22.

Interfacing anaerobic digestion with (bio)electrochemical systems: Potentials and challenges.

De Vrieze J, Arends JBA, Verbeeck K, Gildemyn S, Rabaey K.

Water Res. 2018 Dec 1;146:244-255. doi: 10.1016/j.watres.2018.08.045. Epub 2018 Sep 12. Review.

PMID:
30273809
23.

Objective and Subjective Improvement of Cognition After Discontinuing Efavirenz in Asymptomatic Patients: A Randomized Controlled Trial.

Hakkers CS, Arends JE, van den Berk GE, Ensing MHM, Hooijenga I, Vink M, van Zandvoort MJE, Hoepelman AIM.

J Acquir Immune Defic Syndr. 2019 Jan 1;80(1):e14-e22. doi: 10.1097/QAI.0000000000001876.

PMID:
30272630
24.

Elucidating vancomycin-resistant Enterococcus faecium outbreaks: the role of clonal spread and movement of mobile genetic elements.

Zhou X, Chlebowicz MA, Bathoorn E, Rosema S, Couto N, Lokate M, Arends JP, Friedrich AW, Rossen JWA.

J Antimicrob Chemother. 2018 Dec 1;73(12):3259-3267. doi: 10.1093/jac/dky349.

PMID:
30219855
25.

Adherence to ursodeoxycholic acid therapy in patients with cholestatic and autoimmune liver disease.

Leoni MC, Amelung L, Lieveld FI, van den Brink J, de Bruijne J, Arends JE, van Erpecum CP, van Erpecum KJ.

Clin Res Hepatol Gastroenterol. 2019 Feb;43(1):37-44. doi: 10.1016/j.clinre.2018.08.006. Epub 2018 Sep 13.

PMID:
30219692
26.

REtrieval And cure of Chronic Hepatitis C (REACH): Results of micro-elimination in the Utrecht province.

Kracht PAM, Arends JE, van Erpecum KJ, Thijsen SFT, Vlaminckx BJM, Weersink AJL, Wensing AMJ, Deege MPH, Dimmendaal M, Stadhouders PHGM, Friederich PW, Verhagen MAMT, Boland GJ, Hoepelman AIM.

Liver Int. 2019 Mar;39(3):455-462. doi: 10.1111/liv.13959. Epub 2018 Oct 16.

PMID:
30204289
27.

HIV, HCV and HBV: A Review of Parallels and Differences.

Leoni MC, Ustianowski A, Farooq H, Arends JE.

Infect Dis Ther. 2018 Dec;7(4):407-419. doi: 10.1007/s40121-018-0210-5. Epub 2018 Sep 4. Review.

28.

The Impact of Hepatitis C Virus Direct-Acting Antivirals on Patient-Reported Outcomes: A Dutch Prospective Cohort Study.

Kracht PAM, Lieveld FI, Amelung LM, Verstraete CJR, Mauser-Bunschoten EP, de Bruijne J, Siersema PD, Hoepelman AIM, Arends JE, van Erpecum KJ.

Infect Dis Ther. 2018 Sep;7(3):373-385. doi: 10.1007/s40121-018-0208-z. Epub 2018 Aug 3.

29.

A Novel Shewanella Isolate Enhances Corrosion by Using Metallic Iron as the Electron Donor with Fumarate as the Electron Acceptor.

Philips J, Van den Driessche N, De Paepe K, Prévoteau A, Gralnick JA, Arends JBA, Rabaey K.

Appl Environ Microbiol. 2018 Oct 1;84(20). pii: e01154-18. doi: 10.1128/AEM.01154-18. Print 2018 Oct 15.

30.

Clinical approach to the management of Intestinal Failure Associated Liver Disease (IFALD) in adults: A position paper from the Home Artificial Nutrition and Chronic Intestinal Failure Special Interest Group of ESPEN.

Lal S, Pironi L, Wanten G, Arends J, Bozzetti F, Cuerda C, Joly F, Kelly D, Staun M, Szczepanek K, Van Gossum A, Schneider SM; Home Artificial Nutrition & Chronic Intestinal Failure Special Interest Group of the European Society for Clinical Nutrition and Metabolism (ESPEN).

Clin Nutr. 2018 Dec;37(6 Pt A):1794-1797. doi: 10.1016/j.clnu.2018.07.006. Epub 2018 Jul 9.

PMID:
30017241
31.

A novel high-throughput method for kinetic characterisation of anaerobic bioproduction strains, applied to Clostridium kluyveri.

Candry P, Van Daele T, Denis K, Amerlinck Y, Andersen SJ, Ganigué R, Arends JBA, Nopens I, Rabaey K.

Sci Rep. 2018 Jun 27;8(1):9724. doi: 10.1038/s41598-018-27594-9.

32.

Cancer cachexia: Diagnosis, assessment, and treatment.

Sadeghi M, Keshavarz-Fathi M, Baracos V, Arends J, Mahmoudi M, Rezaei N.

Crit Rev Oncol Hematol. 2018 Jul;127:91-104. doi: 10.1016/j.critrevonc.2018.05.006. Epub 2018 May 31. Review.

PMID:
29891116
33.

Systematic review and meta-analysis of the evidence for oral nutritional intervention on nutritional and clinical outcomes during chemo(radio)therapy: current evidence and guidance for design of future trials.

de van der Schueren MAE, Laviano A, Blanchard H, Jourdan M, Arends J, Baracos VE.

Ann Oncol. 2018 May 1;29(5):1141-1153. doi: 10.1093/annonc/mdy114.

34.

The effect of switching protease inhibitors to raltegravir on endothelial function, in HIV-infected patients.

Krikke M, Tesselaar K, van den Berk GEL, Otto SA, Freriks LH, van Lelyveld SFL, Visseren FJL, Hoepelman AIM, Arends JE.

HIV Clin Trials. 2018 Apr;19(2):75-83. doi: 10.1080/15284336.2018.1455366.

PMID:
29770748
35.

Struggling with nutrition in patients with advanced cancer: nutrition and nourishment-focusing on metabolism and supportive care.

Arends J.

Ann Oncol. 2018 Feb 1;29(suppl_2):ii27-ii34. doi: 10.1093/annonc/mdy093.

PMID:
29741571
36.

HBV and HIV viral load but not microbial translocation or immune activation are associated with liver fibrosis among patients in South Africa.

Maponga TG, Andersson MI, van Rensburg CJ, Arends JE, Taljaard J, Preiser W, Glashoff RH.

BMC Infect Dis. 2018 May 8;18(1):214. doi: 10.1186/s12879-018-3115-8.

37.

An Integrated Proteomic Approach Uncovers Novel Substrates and Functions of the Lon Protease in Escherichia coli.

Arends J, Griego M, Thomanek N, Lindemann C, Kutscher B, Meyer HE, Narberhaus F.

Proteomics. 2018 Jul;18(13):e1800080. doi: 10.1002/pmic.201800080. Epub 2018 Jun 6.

PMID:
29710379
38.

Metacognitive reflection and insight therapy (MERIT) for patients with schizophrenia.

de Jong S, van Donkersgoed RJM, Timmerman ME, Aan Het Rot M, Wunderink L, Arends J, van Der Gaag M, Aleman A, Lysaker PH, Pijnenborg GHM.

Psychol Med. 2019 Jan;49(2):303-313. doi: 10.1017/S0033291718000855. Epub 2018 Apr 25.

PMID:
29692285
39.

Automated video-based detection of nocturnal convulsive seizures in a residential care setting.

Geertsema EE, Thijs RD, Gutter T, Vledder B, Arends JB, Leijten FS, Visser GH, Kalitzin SN.

Epilepsia. 2018 Jun;59 Suppl 1:53-60. doi: 10.1111/epi.14050. Epub 2018 Apr 11.

40.

Movement-based seizure detection.

Arends JBAM.

Epilepsia. 2018 Jun;59 Suppl 1:30-35. doi: 10.1111/epi.14053. Epub 2018 Apr 9. Review.

41.

How to feed patients with gastrointestinal mucositis.

Arends J.

Curr Opin Support Palliat Care. 2018 Jun;12(2):168-173. doi: 10.1097/SPC.0000000000000345. Review.

PMID:
29608464
42.

Multimodal, automated detection of nocturnal motor seizures at home: Is a reliable seizure detector feasible?

van Andel J, Ungureanu C, Arends J, Tan F, Van Dijk J, Petkov G, Kalitzin S, Gutter T, de Weerd A, Vledder B, Thijs R, van Thiel G, Roes K, Leijten F.

Epilepsia Open. 2017 Sep 6;2(4):424-431. doi: 10.1002/epi4.12076. eCollection 2017 Dec.

43.

Prevalence Rate and Risk Factors of Victimization in Adult Patients With a Psychotic Disorder: A Systematic Review and Meta-analysis.

de Vries B, van Busschbach JT, van der Stouwe ECD, Aleman A, van Dijk JJM, Lysaker PH, Arends J, Nijman SA, Pijnenborg GHM.

Schizophr Bull. 2019 Jan 1;45(1):114-126. doi: 10.1093/schbul/sby020.

PMID:
29547958
44.

Towards a comprehensive routine outcome monitoring program for people with psychotic disorders: The Pharmacotherapy Monitoring and Outcome Survey (PHAMOUS).

Bartels-Velthuis AA, Visser E, Arends J, Pijnenborg GHM, Wunderink L, Jörg F, Veling W, Liemburg EJ, Castelein S, Knegtering H, Bruggeman R.

Schizophr Res. 2018 Jan 26. pii: S0920-9964(18)30036-7. doi: 10.1016/j.schres.2018.01.016. [Epub ahead of print]

PMID:
29395613
45.

Defining Multidrug Resistance of Gram-Negative Bacteria in the Dutch-German Border Region-Impact of National Guidelines.

Köck R, Siemer P, Esser J, Kampmeier S, Berends MS, Glasner C, Arends JP, Becker K, Friedrich AW.

Microorganisms. 2018 Jan 26;6(1). pii: E11. doi: 10.3390/microorganisms6010011.

46.

Availability of hepatitis C diagnostics and therapeutics in European and Eurasia countries.

Leblebicioglu H, Arends JE, Ozaras R, Corti G, Santos L, Boesecke C, Ustianowski A, Duberg AS, Ruta S, Salkic NN, Husa P, Lazarevic I, Pineda JA, Pshenichnaya NY, Tsertswadze T, Matičič M, Puca E, Abuova G, Gervain J, Bayramli R, Ahmeti S, Koulentaki M, Kilani B, Vince A, Negro F, Sunbul M, Salmon D; ESGHV (part of ESCMID).

Antiviral Res. 2018 Feb;150:9-14. doi: 10.1016/j.antiviral.2017.12.001. Epub 2017 Dec 5.

PMID:
29217468
47.

Management of drug interactions with direct-acting antivirals in Dutch HIV/hepatitis C virus-coinfected patients: adequate but not perfect.

Smolders EJ, Smit C, de Kanter C, Dofferhoff A, Arends JE, Brinkman K, Rijnders B, van der Valk M, Reiss P, Burger DM; ATHENA National HIV Observational Cohort.

HIV Med. 2018 Mar;19(3):216-226. doi: 10.1111/hiv.12570. Epub 2017 Dec 1.

PMID:
29194939
48.

High Treatment Uptake in Human Immunodeficiency Virus/Hepatitis C Virus-Coinfected Patients After Unrestricted Access to Direct-Acting Antivirals in the Netherlands.

Boerekamps A, Newsum AM, Smit C, Arends JE, Richter C, Reiss P, Rijnders BJA, Brinkman K, van der Valk M; NVHB-SHM Hepatitis Working Group and the Netherlands ATHENA HIV Observational Cohort .

Clin Infect Dis. 2018 Apr 17;66(9):1352-1359. doi: 10.1093/cid/cix1004.

PMID:
29186365
49.

Declining Hepatitis C Virus (HCV) Incidence in Dutch Human Immunodeficiency Virus-Positive Men Who Have Sex With Men After Unrestricted Access to HCV Therapy.

Boerekamps A, van den Berk GE, Lauw FN, Leyten EM, van Kasteren ME, van Eeden A, Posthouwer D, Claassen MA, Dofferhoff AS, Verhagen DWM, Bierman WF, Lettinga KD, Kroon FP, Delsing CE, Groeneveld PH, Soetekouw R, Peters EJ, Hullegie SJ, Popping S, van de Vijver DAMC, Boucher CA, Arends JE, Rijnders BJ.

Clin Infect Dis. 2018 Apr 17;66(9):1360-1365. doi: 10.1093/cid/cix1007.

PMID:
29186320
50.

The Montreal Cognitive Assessment-Basic (MoCA-B) is not a reliable screening tool for cognitive decline in HIV patients receiving combination antiretroviral therapy in rural South Africa.

Hakkers CS, Beunders AJM, Ensing MHM, Barth RE, Boelema S, Devillé WLJ, Tempelman HA, Coutinho RA, Hoepelman AIM, Arends JE, van Zandvoort MJE.

Int J Infect Dis. 2018 Feb;67:36-40. doi: 10.1016/j.ijid.2017.11.024. Epub 2017 Nov 26.

Supplemental Content

Loading ...
Support Center